|
DLD expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.489040E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.955600E-01 |
| Normal-vs-Stage2 |
8.038000E-01 |
| Normal-vs-Stage3 |
9.182700E-03 |
| Normal-vs-Stage4 |
9.452000E-02 |
| Stage1-vs-Stage2 |
9.309000E-01 |
| Stage1-vs-Stage3 |
5.555700E-02 |
| Stage1-vs-Stage4 |
3.395000E-01 |
| Stage2-vs-Stage3 |
1.564600E-01 |
| Stage2-vs-Stage4 |
4.011200E-01 |
| Stage3-vs-Stage4 |
7.564600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.255620E-01 |
| Normal-vs-AfricanAmerican |
5.615000E-01 |
| Normal-vs-Asian |
9.335600E-01 |
| Caucasian-vs-AfricanAmerican |
7.076000E-01 |
| Caucasian-vs-Asian |
8.331800E-01 |
| AfricanAmerican-vs-Asian |
9.364800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.677800E-01 |
| Normal-vs-Female |
2.282800E-01 |
| Male-vs-Female |
5.815800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.567600E-02 |
| Normal-vs-Extreme_Weight |
1.542230E-01 |
| Normal-vs-Obese |
1.564760E-01 |
| Normal-vs-Extreme_Obese |
4.416600E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.633400E-01 |
| Normal_Weight-vs-Obese |
3.803600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.222100E-02 |
| Extreme_Weight-vs-Obese |
9.750800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.341380E-01 |
| Obese-vs-Extreme_Obese |
2.579600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.858200E-02 |
| Normal-vs-Age(41-60Yrs) |
3.472400E-01 |
| Normal-vs-Age(61-80Yrs) |
3.517800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.925750E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.608030E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.456210E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.121200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.637800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.012000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.915400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.048200E-01 |
| Normal-VS-Type2 PRCC |
5.914500E-02 |
| Normal-VS-KIRP CIMP |
6.410800E-04 |
| Normal-VS-Unclassified PRCC |
3.016400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.078000E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.218900E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
1.442230E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.013510E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
7.894200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.386130E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.801800E-02 |
| Normal-vs-N1 |
2.808000E-04 |
| Normal-vs-N2 |
9.6835000018558E-08 |
| N0-vs-N1 |
1.123380E-01 |
| N0-vs-N2 |
1.477820E-01 |
| N1-vs-N2 |
3.595600E-01 |
|
|
